MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

September 2004


Health Care and Law

Advocates Pursue a Public Registry for All Clinical Trials

Dr. Field discusses the benefits and drawbacks of disclosing clinical trial results to the public.
Robert I. Field, JD, MPH, PhD

Partnering for Quality and Patient Safety: A Provider/Payer Collaborative

The authors present an illustration of an innovative Hospital Quality Incentive Payment System for improved patient care.
Mark Baumel, MD, MS, Jeff Danilo, Linda Hart, Steve Brown, MD, Timothy Zeddies, PhD, Kathleen Clark, and Joseph C. Gallo, Jr.

Recent Controversies in Consumer Lawsuits: When Medical Devices Fail

Dr. Goldenberg reviews the role of the FDA, safety issues regarding new medical devices, and some of the possible reasons for their failure and recall.
Marvin M. Goldenberg, PhD, RPh, MS

Continuing Education Credit

Comparative Effects of Available Thiazolidinediones: A Review of the Literature

Dr. Yates discusses the use of two agents, pioglitazone and rosiglitazone, in the treatment of patients with type-2 diabetes after the removal of troglitazone from the market.
Scott W. Yates, MD, MBA



Clinical Trials and Tribulations

David Nash, MD, MBA, details some of the challenges involved in developing the contract language of clinical trials.
David Nash, MD, MBA

Medication Errors

Oral Liquid Medications: More Vulnerable to Errors Than Previously Recognized

Matthew Grissinger, RPh, FASCP, discusses ways to prevent errors involving liquid medications.
Matthew Grissinger, RPh, FASCP

Letters to the Editor

Prescription: Washington

Surf’s Up! New Electronic Health Records Initiative Creates Waves

Stephen Barlas discusses a large-scale effort to accelerate the arrival of electronic health records for patients in the U.S.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

P&T presents the latest information about FDA approvals, drug indications, industry updates, and new devices.

Drug Forecast

Risperdal Consta™: The First Long-Acting Atypical Antipsychotic Agent

The authors review risperidone (Risperdal Consta™), the first long-acting atypical antipsychotic agent.
Suzanne Thompson, PharmD, and Jose A. Rey, PharmD